| pre-miRNA Information | |
|---|---|
| pre-miRNA | hsa-mir-6888 |
| Genomic Coordinates | chr2: 159186835 - 159186901 |
| Description | Homo sapiens miR-6888 stem-loop |
| Comment | None |
| RNA Secondary Structure |  |
| Mature miRNA Information | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mature miRNA | hsa-miR-6888-5p | |||||||||||||||
| Sequence | 6| AAGGAGAUGCUCAGGCAGAU |25 | |||||||||||||||
| Evidence | Experimental | |||||||||||||||
| Experiments | Meta-analysis | |||||||||||||||
| SNPs in miRNA |
|
|||||||||||||||
| Putative Targets | ||||||||||||||||
| Gene Information | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Symbol | CEP97 | ||||||||||||||||||||
| Synonyms | 2810403B08Rik, LRRIQ2 | ||||||||||||||||||||
| Description | centrosomal protein 97 | ||||||||||||||||||||
| Transcript | NM_024548 | ||||||||||||||||||||
| Expression | |||||||||||||||||||||
| Putative miRNA Targets on CEP97 | |||||||||||||||||||||
| 3'UTR of CEP97 (miRNA target sites are highlighted) |
>CEP97|NM_024548|3'UTR 1 CATGTCTTTTGGGAGGCAGATATCCACTTAACTTTTCTTAAAAATACTTTCAGTTGCCTTTGCTTTTTTTTGGAGGGAAA 81 TACTCCCTACCCCTAATTTTGTTACTACTTATATAGAATTTGTATTCATGTCTTATATTTTTCAGATTCTAGATATTGAG 161 CTGAGTTTTCATTTTGATTTTGTTAGCTTTTTACTTAGCTGTAAGGTACCAAACTATTTATATTGAAAGCTATATGCACT 241 TTATTTCTTAACTGAATTGCATCAACAATGTTCCTGTTTCTTTCATGTACTCATTTACTTTCAAAAATAAGCTAGAATAT 321 ATTAAAGAAAATAGAAAAAATTACCTTAAATATATAAATAAGAGAATTTTGGCCCTTCTGTGTCTGAGAAAATTAATTAT 401 ATAGCAAGGAATGAAATTTGATAAAGCAAATATAAATGAGAAATATGAGGATTGTGAATTATTGAAATTTGCCAGTCTCC 481 CTGGTGTAAAATGTTTTTTTAAAGCCTTTTTTCCTCCTTTCGGAGTCAAGGAAAGCCTTTCTATAAGCAAATTAAGGAAG 561 AAAAGGTAGGATTATAAGATTTCTCAATGGGGATGATTAAATTGTCTCATGGAAAACTTCAGTTAATGTCATGCATCAGT 641 TTTAACATATGAAGTAAAGTGTTCTATCCAGGATTAAAGTCAAGTTTACTTAGGCAACACAAGAATATTTCACTTAGATA 721 TGAAGAAAGGAAACACTAGTCTCCATTCACTTGAAATACTCTCATGGCAAATATTTATCCTCTCATTAAGTGCTTTTTCA 801 CCCTATAGGTAAGCATTTTTGTGCCAACATGTTGTCAGAAATTAATGTATGTTCATCTCCTCTGTTCCTGCTTATTTTTA 881 CTTATATATTTCAGCAGAAGGTCCGTGGCCATTCACTTCAATTTTGACCTCTGTCCCATAGTGAAGAACATTTAAAGTAA 961 TACTACTGGTCGAATATGAATGACTTTTTAGGAACTACTTTTTGTCTAACCTGAAAAAGTTCCACATTTGGAAGACAATT 1041 TAATGATGGTGAAGAAATAATAAACCTCACTTTACTTGTTAAAAGGGATATATATATATATATATATGTCTGCAACTTCA 1121 GGGAGAAATAAGATTGTGTTTGAATATTGTAGGTAGATGCATTTGTAATTAAGGATAATATCGTTTAACAACATGTATTT 1201 GGTTTCCCTCAACTTACAGACATACAGCTATTTAAAACTATGGCAATACTTAAGCATCTCTAAATTTAGGTGCTAAATAT 1281 CTATTATTCTGTTGTAGTCATTAGGTGCCCTTCTCTGAAGTTATGTAAAATAAAAGCATCTGATCCTTCAAGGATAAAGT 1361 TGAGGATCACATGGTACGTGGCATTTGTTGTTATTGTTTTTTAAAGAGATGGAGGCTGGCTCTGTTGGTGCGGTGCCATG 1441 ATCATAGTTCACTATAACCTCGAACTCCTGGCTCAAGTGATCTCCCACTTCAGCCTCCCGAGTATCTGGGATTATAAGCA 1521 AGAGCCACTGCTCCCAGCTCATGGTATTTGTTGATAGTCATAACATTTTTCCTGTATGGTAAGACGTATTTTTCTCAGTT 1601 TATAAATACGTAGCACTCAGGTTGAGACGACTTGGATTTTATTCTTAGAAATCCAGAATCCCTTGAAAAGGAAATATTTT 1681 CTGTTTCTTATAAATAAAAGAGTAATCTTACTTTCAGAAGGATTTTCCTTAGTGAAACATGTGTAACATTGAATGCATGT 1761 TAAATAAAAATGGAATTTCTAACTTTTTTTCAATAGTGCTAATTATCTTTTCTGAATGATTTTGAATGTCTTCTTAAATA 1841 TACCCTATTTTTCTATTTTAAAGTTAAGTGCCTCACTTGCTGTCCATAGTTAGACAAAGAAAAACCAATTTCCACTGCAC 1921 TAGTACCAAAATACTACTTTATACATTAGTTTTTCATAAAAGCTGCTGGAATGTCATGATTCAGTATTACCTAAATAGAT 2001 TTCTGCTAAAATCCTCTCCCTCCTGTCTTTTTTAAGTTATGGAAAAACACAACTAAATTCATTTGATCATCAGCACTTGT 2081 TAGCAGGATTTCCTTTTTTACCTTTGCCTTGTTTCTTTAGCCCACAAATAGTACTCAGCATACTTTCATTAAAAATTTGG 2161 CACAATATGATAATTGTTAATATTCTGTTCTTCGTCTGTGTTTTATTTAACTTTTACTAGTGTTTAGAAGTGCAAGAATA 2241 TTAAATAGCCCCTTCCTTAACTGTACATATTATCTTGAATGTAGATAAAATGAAAATACTGTAAATTAGAGTGTAGGAAA 2321 ACTGGCATAGAGTTAATATATTTTAATGGGTTTACATTATACTTTAAAAGTAATTTATATAATTAAAATATTTGGTTTTA 2401 ACTCTATGGGCTATTCTTTGGTTGGCTGAAGAGGGAATGGGTCTAGTAAGGTTTGGAAAGTTAAGCTTTGAACATGGTCT 2481 TTGTGTTTTTTTCCTAACAAGGAAAGGTTTAGTTCAGCTGTGCTATTTTAGTACACATCAGTTCTCTTGATTTATGGAAG 2561 ATTCAGTTTATCAATTAAGAATTCCTGCAGAAGCACAGAATCATACCATGTAAGAGTTGGAAGGAAGCTTAAGAGATTTC 2641 TGTTCGAATCTCTTTGTTTCAAAGATGAAACTAAAGCACAGCATGTTAAATGACTTGTCTAAGTTATAGCTAGTTAGTAG 2721 TAAATAAACTGAAAACCTATATGCTACTGTAGTCCAAAATTTTATTATGTCCTCTTAATCTTTACATTTAGTGAGTCAGT 2801 AAGGAAATCTCTGCATATTTCTCATTCTCTTTGAAAGAGGAAAAAAACTTCTAAGAGAGCTACAACTCTATCACTCATGA 2881 CAGAGTTGCTTGTAGAAAATAACTAATTCCTTCAGAACCCTGAGTGAATTTTTTCTAAGAAATGTGACTTGATTAAAATG 2961 GTTTCAAAAGAGCAATAGTGGAAATTAAAGTTTTAGAAAAGAGACCTGGCGTGGTGGTTGACAACTGTAATCCCAGTGCT 3041 TTGGGAGGCTGAGGCCAGAGGATCACTTGAGGCCAGGAGTTCAAGACCAGCCTGGACAACATAGCAAGACCCCCCTCTCT 3121 ACAAAAAAAATTTTTTTCTGAAAAGAATAAGTACATTTTAGAGTCCATTTATTTGACGACAGGCAGTATGACAGGTTGCT 3201 GAGGTATATAAAATTTTCTAGAGAAATGCTGAGTTTGATGACATTTTATCTTCAGTTTTGTAGAACAGATGTTAAAATGT 3281 TAACTCTCCTGGTGTGCAGAAAGCTGTAATCATGACAGTTGATAATATGCAATTTAGTTTGATTTTATAGGTTTAATTAT 3361 AAAAGGCTTCACAATATGCATGTTTTAGGAAAATGTTCATTTATTTAGTCATATAATCGTTTGTATATATGTAAATAACT 3441 TTATTCTGGAATAATGTGGGTGCCATCTTGAGCGTGTGTTTTTATCTGTTTTGGATTATTTTTTGTATACAAACACCATA 3521 ATACTGTATTTTCCTGTTATCTACTTAAGTCTAGTTCTACTTTTTCCCAATAATTTCAGGAAAATACAAGCTTGAGATAT 3601 TATACTATCTCCCTTGGTATTTTTTGTGTGCAAAGTCTTAGAATTGGATTTATAACATTGATAATAAAAATATAAAACGT 3681 TTTTCCTCGGGAGTTAAGATGGTAAAAAGAAAAAAATAGAATGAATATGATCATTTCTCCATCATAAAGGAAAGAAGAGA 3761 CTTCATTGTGTGTGTGTTTTTTTTTTTTTTTTCGAGATAGAGTTTCACTGTTGTCACCCAGGCTGGTCTCAGCTCACTGC 3841 AACCTCCACTTCCTGGGTACAAGCGATTCTCCTGCCTCAGCTTCCTGTGTAGCTGGGATTACAGGTGTGCAACCACAAGG 3921 CTCGGCTAATTTTTTTGTATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAA 4001 GTGATCCACCCACCTCGGCCTCGCAAAGTGCTGAGATTACAGGTGTGAGCCACTGTGCCCAGCCGAGACTTCATTGTTTA 4081 ATGTATATTTTTATTTTTTCCAAACACCAGCTCGAATCAGAGTATATTTTTATTTTGCCACATACCTTTAAAAGGTATTT 4161 ATTGTGTCATAATGTTTTAAATGTTAAATATATGATACCCTCATTCATGAAGTGAAGCAGAAAGGGTCTGTAAGGAACAT 4241 TCTAAACATTTTTAATGATATTGCTTTTACTGATCAAGCTTGTTGTGCCATATTAAAATTAAAAGTCAAATAAACAAAGC 4321 AGTCCTCACAGCCTTGGAAAGAAATAGATAATTGTCTTCTTAAGATGAGGTGCTTTTTATCTGTGGATGAATGGAAATCA 4401 CACTGAATTTTAATTCTTATTTATTTTAGTGGATAGCAGGAATCACTCTGTAGTAGTTGTGTTCATTTTCTTTTCTTTTT 4481 CTTTTCTTTTTTTTGAGAGAGTCTCGCTCTGTCACCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCACTGCAACCTCCA 4561 TCTCCTGGGTTCAAGTGATTCTCCTGCCTCATCCTCCCGAGTAGCTAAGACTACAGGCACACGCCACCATGCCCAGCTAA 4641 TTTTTATATTTTTAGTAGAGATGGGGTTTCACCATGTTGGCCAGGATGGTCTCAATCTCTTGACCTCGTGATCCACCCAG 4721 TTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACTACACCTGGCCTTGTTCATCTTCTAATTAAATATCTTTGA 4801 ATGTTTTGTAATAATTTTAATGTTGACAATAAGAGTTTAAAAATAATTTGATTTTGGACTGTATTTAGATTTCTCTTTAA 4881 TTTTGCTGTAGAAATAGTAAATGATTTAAAGTGGTTATGATGTGTTTTATGAAGGCTTACTATTTTATATTGTACTTATT 4961 TAATTTGTATTTGAGTCTGTCTAATTTTAAATAAAAGGTTTATACATTTGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
| miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
| DRVs in gene 3'UTRs | |||||||||||||||||||||
| SNPs in gene 3'UTRs | |||||||||||||||||||||
| Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
|---|---|---|---|---|---|---|---|
| miRNA:Target | ---- | ||||||
| Validation Method |
|
||||||
| Conditions | TZM-bl | ||||||
| Location of target site | 3'UTR | ||||||
| Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
| Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
| miRNA-target interactions (Provided by authors) |
|
||||||
| Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
||||||
| Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
|---|---|---|---|---|---|---|---|
| miRNA:Target | ---- | ||||||
| Validation Method |
|
||||||
| Conditions | HCT116 | ||||||
| Location of target site | 3'UTR | ||||||
| Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
| Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177633. RNA binding protein: AGO2. Condition:KO_D_AGO_CLIP_4_11
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
||||||
| miRNA-target interactions (Provided by authors) |
|
||||||
| Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
||||||
| Experimental Support 3 for Functional miRNA-Target Interaction | |
|---|---|
| miRNA:Target | ---- |
| Validation Method |
|
| Conditions | Prostate Tissue |
| Location of target site | 3'UTR |
| Tools used in this research | TargetScan , miRTarCLIP , Piranha |
| Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760638. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3-miR148
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
| Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
| CLIP-seq Support 1 for dataset GSM1462574 | |
|---|---|
| Method / RBP | PAR-CLIP / AGO2 |
| Cell line / Condition | TZM-bl / TZM-bl ami BaL |
| Location of target site | ENST00000341893.3 | 3UTR | CUCACUGCAACCUCCAUCUCCUGGGUUCAAG |
| Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
| Article / Accession Series | PMID: 23592263 / GSE59944 |
| CLIP-seq Viewer | Link |
| MiRNA-Target Expression Profile | |||||||
|---|---|---|---|---|---|---|---|
|
| MiRNA-Target Expression Profile (TCGA) | |||||||
|---|---|---|---|---|---|---|---|
|
110 hsa-miR-6888-5p Target Genes:
Functional analysis:
ID |
Target | Description | Validation methods |
 |
 |
|||||||
| Strong evidence | Less strong evidence | |||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|||||
| MIRT100971 | CENPQ | centromere protein Q |  |
|
2 | 4 | ||||||
| MIRT177381 | WAC | WW domain containing adaptor with coiled-coil | |
|
2 | 4 | ||||||
| MIRT215237 | NPM1 | nucleophosmin 1 | |
|
2 | 4 | ||||||
| MIRT264969 | TMEM136 | transmembrane protein 136 | |
|
2 | 2 | ||||||
| MIRT306298 | KLHL24 | kelch like family member 24 | |
|
2 | 2 | ||||||
| MIRT319712 | UBN2 | ubinuclein 2 | |
|
2 | 2 | ||||||
| MIRT332866 | TXNIP | thioredoxin interacting protein | |
|
2 | 2 | ||||||
| MIRT444384 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | |
|
2 | 2 | ||||||
| MIRT445270 | CPPED1 | calcineurin like phosphoesterase domain containing 1 | |
|
2 | 2 | ||||||
| MIRT447185 | PGRMC2 | progesterone receptor membrane component 2 | |
|
2 | 2 | ||||||
| MIRT448763 | HDX | highly divergent homeobox | |
|
2 | 2 | ||||||
| MIRT451468 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | |
|
2 | 2 | ||||||
| MIRT452754 | U2AF2 | U2 small nuclear RNA auxiliary factor 2 | |
|
2 | 2 | ||||||
| MIRT455325 | TTLL9 | tubulin tyrosine ligase like 9 | |
|
2 | 2 | ||||||
| MIRT456846 | ZNF460 | zinc finger protein 460 | |
|
2 | 2 | ||||||
| MIRT457372 | POFUT2 | protein O-fucosyltransferase 2 | |
|
2 | 2 | ||||||
| MIRT460352 | ARL14EP | ADP ribosylation factor like GTPase 14 effector protein | |
|
2 | 2 | ||||||
| MIRT462004 | SNRNP27 | small nuclear ribonucleoprotein U4/U6.U5 subunit 27 | |
|
2 | 2 | ||||||
| MIRT462104 | TMEM214 | transmembrane protein 214 | |
|
2 | 2 | ||||||
| MIRT465309 | TRAM2 | translocation associated membrane protein 2 | |
|
2 | 2 | ||||||
| MIRT468841 | RRM2 | ribonucleotide reductase regulatory subunit M2 | |
|
2 | 4 | ||||||
| MIRT469635 | RAD21 | RAD21 cohesin complex component | |
|
2 | 6 | ||||||
| MIRT470181 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | |
|
2 | 4 | ||||||
| MIRT471782 | NUP153 | nucleoporin 153 | |
|
2 | 2 | ||||||
| MIRT472261 | NFIC | nuclear factor I C | |
|
2 | 2 | ||||||
| MIRT473731 | MAPK1 | mitogen-activated protein kinase 1 | |
|
2 | 2 | ||||||
| MIRT477728 | EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | |
|
2 | 2 | ||||||
| MIRT479358 | CEP97 | centrosomal protein 97 | |
|
2 | 2 | ||||||
| MIRT481063 | BASP1 | brain abundant membrane attached signal protein 1 | |
|
2 | 2 | ||||||
| MIRT482044 | AMER1 | APC membrane recruitment protein 1 | |
|
2 | 2 | ||||||
| MIRT482892 | IAH1 | isoamyl acetate-hydrolyzing esterase 1 homolog | |
|
2 | 4 | ||||||
| MIRT485773 | B4GALT5 | beta-1,4-galactosyltransferase 5 | |
|
2 | 2 | ||||||
| MIRT492646 | PLEKHM3 | pleckstrin homology domain containing M3 | |
|
2 | 2 | ||||||
| MIRT501915 | MBD4 | methyl-CpG binding domain 4, DNA glycosylase | |
|
2 | 4 | ||||||
| MIRT503022 | CAND1 | cullin associated and neddylation dissociated 1 | |
|
2 | 2 | ||||||
| MIRT503247 | ZFP36 | ZFP36 ring finger protein | |
|
2 | 4 | ||||||
| MIRT504591 | FAM103A1 | family with sequence similarity 103 member A1 | |
|
2 | 6 | ||||||
| MIRT507346 | FAM168A | family with sequence similarity 168 member A | |
|
2 | 2 | ||||||
| MIRT508274 | DYNLL2 | dynein light chain LC8-type 2 | |
|
2 | 4 | ||||||
| MIRT508414 | C1orf210 | chromosome 1 open reading frame 210 | |
|
2 | 6 | ||||||
| MIRT508956 | SNRPB | small nuclear ribonucleoprotein polypeptides B and B1 | |
|
2 | 4 | ||||||
| MIRT514698 | SOD2 | superoxide dismutase 2 | |
|
2 | 2 | ||||||
| MIRT515837 | MCM8 | minichromosome maintenance 8 homologous recombination repair factor | |
|
2 | 4 | ||||||
| MIRT516095 | ZBTB8OS | zinc finger and BTB domain containing 8 opposite strand | |
|
2 | 4 | ||||||
| MIRT516420 | ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif 4 | |
|
2 | 2 | ||||||
| MIRT516863 | TYW5 | tRNA-yW synthesizing protein 5 | |
|
2 | 2 | ||||||
| MIRT516940 | MRRF | mitochondrial ribosome recycling factor | |
|
2 | 2 | ||||||
| MIRT518122 | RNMTL1 | mitochondrial rRNA methyltransferase 3 | |
|
2 | 4 | ||||||
| MIRT522745 | LNPEP | leucyl and cystinyl aminopeptidase | |
|
2 | 2 | ||||||
| MIRT523816 | FAM179A | TOG array regulator of axonemal microtubules 2 | |
|
2 | 2 | ||||||
| MIRT524107 | DNA2 | DNA replication helicase/nuclease 2 | |
|
2 | 2 | ||||||
| MIRT526722 | RPS9 | ribosomal protein S9 | |
|
2 | 2 | ||||||
| MIRT527047 | ISY1-RAB43 | ISY1-RAB43 readthrough | |
|
2 | 2 | ||||||
| MIRT534174 | SLC8A1 | solute carrier family 8 member A1 | |
|
2 | 2 | ||||||
| MIRT537151 | GJA1 | gap junction protein alpha 1 | |
|
2 | 2 | ||||||
| MIRT544174 | BHLHB9 | basic helix-loop-helix family member b9 | |
|
2 | 2 | ||||||
| MIRT544558 | CSNK2A1 | casein kinase 2 alpha 1 | |
|
2 | 2 | ||||||
| MIRT544569 | POLDIP3 | DNA polymerase delta interacting protein 3 | |
|
2 | 2 | ||||||
| MIRT545174 | SPATA18 | spermatogenesis associated 18 | |
|
2 | 2 | ||||||
| MIRT545478 | TRIM37 | tripartite motif containing 37 | |
|
2 | 2 | ||||||
| MIRT549771 | ZNF611 | zinc finger protein 611 | |
|
2 | 4 | ||||||
| MIRT550733 | PMPCA | peptidase, mitochondrial processing alpha subunit | |
|
2 | 4 | ||||||
| MIRT550864 | SNAP47 | synaptosome associated protein 47 | |
|
2 | 4 | ||||||
| MIRT551297 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | |
|
2 | 6 | ||||||
| MIRT551325 | GSG2 | histone H3 associated protein kinase | |
|
2 | 6 | ||||||
| MIRT552807 | XIAP | X-linked inhibitor of apoptosis | |
|
2 | 4 | ||||||
| MIRT555345 | PPP1R3B | protein phosphatase 1 regulatory subunit 3B | |
|
2 | 4 | ||||||
| MIRT558137 | ENPP4 | ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) | |
|
2 | 2 | ||||||
| MIRT560877 | SULT1B1 | sulfotransferase family 1B member 1 | |
|
2 | 2 | ||||||
| MIRT561906 | SMCR7L | mitochondrial elongation factor 1 | |
1 | 1 | |||||||
| MIRT564414 | EMILIN2 | elastin microfibril interfacer 2 | |
|
2 | 4 | ||||||
| MIRT568716 | TMEM30B | transmembrane protein 30B | |
|
2 | 2 | ||||||
| MIRT573284 | NCAPH | non-SMC condensin I complex subunit H | |
|
2 | 2 | ||||||
| MIRT573685 | HES6 | hes family bHLH transcription factor 6 | |
|
2 | 2 | ||||||
| MIRT618161 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | |
|
2 | 2 | ||||||
| MIRT622840 | PDZD4 | PDZ domain containing 4 | |
|
2 | 2 | ||||||
| MIRT624355 | CHRM3 | cholinergic receptor muscarinic 3 | |
|
2 | 2 | ||||||
| MIRT642273 | SMIM17 | small integral membrane protein 17 | |
|
2 | 2 | ||||||
| MIRT652967 | SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | |
|
2 | 2 | ||||||
| MIRT666642 | RBMS2 | RNA binding motif single stranded interacting protein 2 | |
|
2 | 2 | ||||||
| MIRT680851 | ARL8B | ADP ribosylation factor like GTPase 8B | |
|
2 | 2 | ||||||
| MIRT681368 | BRI3BP | BRI3 binding protein | |
|
2 | 2 | ||||||
| MIRT681551 | ZNF738 | zinc finger protein 738 | |
|
2 | 2 | ||||||
| MIRT681667 | DTX3L | deltex E3 ubiquitin ligase 3L | |
|
2 | 2 | ||||||
| MIRT681808 | EIF4A3 | eukaryotic translation initiation factor 4A3 | |
|
2 | 2 | ||||||
| MIRT681955 | SLC19A3 | solute carrier family 19 member 3 | |
|
2 | 2 | ||||||
| MIRT682192 | SLC38A7 | solute carrier family 38 member 7 | |
|
2 | 2 | ||||||
| MIRT682249 | SAR1A | secretion associated Ras related GTPase 1A | |
|
2 | 2 | ||||||
| MIRT682396 | PHACTR4 | phosphatase and actin regulator 4 | |
|
2 | 2 | ||||||
| MIRT685160 | DTWD2 | DTW domain containing 2 | |
|
2 | 2 | ||||||
| MIRT687030 | RNF24 | ring finger protein 24 | |
|
2 | 2 | ||||||
| MIRT688377 | ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | |
|
2 | 2 | ||||||
| MIRT690383 | ZSWIM7 | zinc finger SWIM-type containing 7 | |
|
2 | 2 | ||||||
| MIRT691949 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | |
|
2 | 2 | ||||||
| MIRT693036 | MB21D1 | Mab-21 domain containing 1 | |
|
2 | 2 | ||||||
| MIRT693110 | SCNM1 | sodium channel modifier 1 | |
|
2 | 2 | ||||||
| MIRT694481 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | |
|
2 | 2 | ||||||
| MIRT694898 | ZNF417 | zinc finger protein 417 | |
|
2 | 2 | ||||||
| MIRT696667 | AGXT2 | alanine--glyoxylate aminotransferase 2 | |
|
2 | 2 | ||||||
| MIRT698663 | TERF2 | telomeric repeat binding factor 2 | |
|
2 | 2 | ||||||
| MIRT700157 | RNF115 | ring finger protein 115 | |
|
2 | 2 | ||||||
| MIRT700984 | PDE4D | phosphodiesterase 4D | |
|
2 | 2 | ||||||
| MIRT702139 | MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5 | |
|
2 | 2 | ||||||
| MIRT702207 | LPP | LIM domain containing preferred translocation partner in lipoma | |
|
2 | 2 | ||||||
| MIRT702496 | KIAA1328 | KIAA1328 | |
|
2 | 2 | ||||||
| MIRT704932 | CCDC36 | coiled-coil domain containing 36 | |
|
2 | 2 | ||||||
| MIRT705778 | ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | |
|
2 | 2 | ||||||
| MIRT707795 | TTYH3 | tweety family member 3 | |
|
2 | 2 | ||||||
| MIRT711479 | MYH15 | myosin heavy chain 15 | |
|
2 | 2 | ||||||
| MIRT713188 | ERO1L | endoplasmic reticulum oxidoreductase 1 alpha | |
1 | 1 | |||||||